
Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.
Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.
Although there is no scientific evidence that a specific diet reduces risk of infection in patients experiencing neutropenia, it is a common strategy in cancer care. Research presented at the 42nd Annual Congress of the Oncology Nursing Society determined that the popular neutropenic diet can be eliminated from practice.
An update on the latest developments in the world of oncology care: product approvals, clinical developments, health policy changes, and more.
Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press
Intuniv, a once-daily non-stimulant from Shire and Shionogi for adults with attention-deficit/hyperactivity disorder, met its primary endpoint and showed a superior change from baseline compared with placebo in a phase 3 study.
Patients with rheumatoid arthritis (RA) have an increased risk of cardiovascular disease, making it important to assess the risk factors that influence RA so physicians can better treat high-risk patients.
Coverage of our peer-reviewed research in the healthcare and mainstream press.
Coverage of our peer-reviewed research in the healthcare and mainstream press.
259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512
© 2025 MJH Life Sciences®
All rights reserved.